XML 102 R88.htm IDEA: XBRL DOCUMENT v3.25.0.1

INCOME TAX - Additional Information (Details) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Income Tax Disclosure [Line Items]
Capitalized research and experimental expenditures in deferred tax assets	$ 157,812	$ 130,972
Loss and credit carryforwards	5,836	7,430
Valuation allowance	794	0
Uncertain tax liability	32,200	22,100
Unrecognized tax benefit that would impact tax rate if recognized	28,600	$ 20,100	$ 13,300
State Research and Development Credit Carryforward
Income Tax Disclosure [Line Items]
Valuation allowance	$ 800

X

- Definition

Deferred Tax Assets, Operating Loss And Tax Credit Carryforwards

+ References

No definition available.

+ Details

Name:	tyl_DeferredTaxAssetsOperatingLossAndTaxCreditCarryforwards
Namespace Prefix:	tyl_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

X

- Definition

Income Tax Disclosure

+ References

No definition available.

+ Details

Name:	tyl_IncomeTaxDisclosureLineItems
Namespace Prefix:	tyl_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Taxes Payable, Non-Current

+ References

No definition available.

+ Details

Name:	tyl_TaxesPayableNonCurrent
Namespace Prefix:	tyl_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

X

- Definition

Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from in-process research and development cost acquired in business combination or from joint venture formation or both.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-6

+ Details

Name:	us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

X

- Definition

Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-2

+ Details

Name:	us-gaap_DeferredTaxAssetsValuationAllowance
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

X

- Definition

The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 217
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482663/740-10-55-217

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 15A
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A

+ Details

Name:	us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

X

- Details

Name:	us-gaap_ValuationAllowanceByDeferredTaxAssetAxis=tyl_StateResearchAndDevelopmentCreditCarryforwardMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: